Atrius India Core FHIR Implementation Guide
0.1.0 - ci-build
Atrius India Core FHIR Implementation Guide - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://atrius.in/fhir/r4/atrius-in/ValueSet/atrius-vs-macrolides | Version: 0.1.0 | ||||
| Active as of 2026-07-24 | Computable Name: AtriusVsMacrolides | ||||
| Other Identifiers: OID:1.3.6.1.4.1.66219.1.48.25 | |||||
Macrolide antibiotics with clinically significant CYP3A4 inhibition (statin interaction). Azithromycin is deliberately excluded (safer alternative).
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
This value set includes codes based on the following rules:
http://snomed.info/sct version Not Stated (use latest from terminology server)| Code | Display |
| 387487009 | Clarithromycin |
| 372694001 | Erythromycin |
http://www.nlm.nih.gov/research/umls/rxnorm version Not Stated (use latest from terminology server)
| Code | Display |
| 21212 | clarithromycin |
| 4053 | erythromycin |
Expansion from 127.0.0.1 based on:
This value set contains 4 concepts
| System | Code | Display (en) | JSON | XML |
http://snomed.info/sct | 387487009 | Clarithromycin | ||
http://snomed.info/sct | 372694001 | Erythromycin | ||
http://www.nlm.nih.gov/research/umls/rxnorm | 21212 | clarithromycin | ||
http://www.nlm.nih.gov/research/umls/rxnorm | 4053 | erythromycin |